Protein AF-9 (MLLT3) Peptide
MLLT3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN938080
Quick Overview for Protein AF-9 (MLLT3) Peptide (ABIN938080)
Target
AF9 (MLLT3)
(Protein AF-9 (MLLT3))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- ERHILQQIVN LIEETGHFHI TNTTFDFDLC SLDKTTVRKL QSYLETSGTS
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MLLT3 antibody,
Alternative Names: MLLT3 control peptide, MLLT3 antibody Blocking Peptide, Anti-MLLT3 Blocking Peptide, myeloid/lymphoid or mixed-lineage leukemia, trithorax homolog, Drosophila, translocated to, 3 Blocking Peptide, AF9 Blocking Peptide, FLJ2035 Blocking Peptide, YEATS3 Blocking Peptide, MLLT3, MLLT-3, MLLT 3, MLLT-3 Blocking Peptide, MLLT 3 Blocking Peptide -
Purification
- The antibody is affinity purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- AF9 (MLLT3) (Protein AF-9 (MLLT3))
-
Background
- MLLT3 is a regulator of early erythroid and megakaryocytic cell fate in the human system. Expression of MLLT3 in human CD34+ cells induces acute myeloid, lymphoid, or mixed-lineage leukemia in immunodeficient mice.
-
Molecular Weight
- 37 kDa
Target
-
You are here:
